The Royal Marsden NHS Foundation Trust
About The Royal Marsden NHS Foundation Trust
The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.
Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehensive cancer centre in Europe, treating over 50,000 NHS and private patients every year. It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education.
The Royal Marsden, with the ICR, is the only National Institute for Health Research Biomedical Research Centre for cancer. First awarded the status in 2006, it was re-awarded in 2011. A total of £62 million is being provided over five years to support pioneering research work, and is being shared across eight different cancer themes.
We have two hospitals: one in Chelsea, London, and another in Sutton, Surrey. We also have a Chemotherapy Medical Daycare Unit at Kingston Hospital. The Royal Marsden also provides community services in the London boroughs of Sutton and Merton and in June 2010, along with the ICR, The Royal Marsden launched a new academic partnership with Mount Vernon Cancer Centre in Middlesex.
Since 2004, the hospital’s charity, The Royal Marsden Cancer Charity, has helped raise over £100 million to build theatres, diagnostic centres and drug development units.
HRH The Duke of Cambridge became President of The Royal Marsden in 2007, following a long royal connection with the hospital.